- Home
- EMCG vs NTRB Comparison
EMCG vs NTRB Comparison
Compare EMCG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMCG
- NTRB
- Stock Information
- Founded
- EMCG 2021
- NTRB 2016
- Country
- EMCG United States
- NTRB United States
- Employees
- EMCG N/A
- NTRB N/A
- Industry
- EMCG
- NTRB Industrial Specialties
- Sector
- EMCG
- NTRB Health Care
- Exchange
- EMCG NYSE
- NTRB Nasdaq
- Market Cap
- EMCG N/A
- NTRB 59.1M
- IPO Year
- EMCG 2022
- NTRB N/A
- Fundamental
- Price
- EMCG $12.15
- NTRB $10.72
- Analyst Decision
- EMCG
- NTRB Buy
- Analyst Count
- EMCG 0
- NTRB 1
- Target Price
- EMCG N/A
- NTRB $13.00
- AVG Volume (30 Days)
- EMCG 146.0
- NTRB 115.7K
- Earning Date
- EMCG 01-01-0001
- NTRB 05-30-2025
- Dividend Yield
- EMCG N/A
- NTRB N/A
- EPS Growth
- EMCG N/A
- NTRB N/A
- EPS
- EMCG 0.19
- NTRB N/A
- Revenue
- EMCG N/A
- NTRB $2,398,437.00
- Revenue This Year
- EMCG N/A
- NTRB $560.75
- Revenue Next Year
- EMCG N/A
- NTRB $588.39
- P/E Ratio
- EMCG $65.56
- NTRB N/A
- Revenue Growth
- EMCG N/A
- NTRB 18.92
- 52 Week Low
- EMCG $11.21
- NTRB $3.72
- 52 Week High
- EMCG $13.39
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- EMCG 97.58
- NTRB 81.37
- Support Level
- EMCG $11.76
- NTRB $7.52
- Resistance Level
- EMCG $11.97
- NTRB $8.41
- Average True Range (ATR)
- EMCG 0.02
- NTRB 0.61
- MACD
- EMCG -0.00
- NTRB 0.14
- Stochastic Oscillator
- EMCG 100.00
- NTRB 79.51
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.